TABLE OF CONTENTS
|  | | | Volume 107, Issue 8 (1205-1444)
Published online 9 October 2012
|  | In this issue
 Editorial
Minireview
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics and Genomics
Letters to the Editor
Also new today
 Advance online publication
| | | | | | Advertisement | | | | | | | Editorial | Top | | Emergency admissions of cancer as a marker of diagnostic delay W Hamilton Br J Cancer 2012 107: 1205-1206; 10.1038/bjc.2012.423 Full Text | | Minireview | Top | | Endothelial cell metabolism and implications for cancer therapy U Harjes, K Bensaad and A L Harris Br J Cancer 2012 107: 1207-1212; 10.1038/bjc.2012.398 Abstract | Full Text | | Clinical Studies | Top | | Association between patient and general practice characteristics and unplanned first-time admissions for cancer: observational study A Bottle, C Tsang, C Parsons, A Majeed, M Soljak and P Aylin Br J Cancer 2012 107: 1213-1219; advance online publication, July 24, 2012; 10.1038/bjc.2012.320 Abstract | Full Text | | | | Routes to diagnosis for cancer – determining the patient journey using multiple routine data sets L Elliss-Brookes, S McPhail, A Ives, M Greenslade, J Shelton, S Hiom and M Richards Br J Cancer 2012 107: 1220-1226; advance online publication, September 20, 2012; 10.1038/bjc.2012.408 Abstract | Full Text | | | | Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies G Procopio, E Verzoni, R Iacovelli, D Biasoni, I Testa, L Porcu and F De Braud Br J Cancer 2012 107: 1227-1232; advance online publication, September 11, 2012; 10.1038/bjc.2012.327 Abstract | Full Text | | | | RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma J Kurashige, M Watanabe, M Iwatsuki, K Kinoshita, S Saito, Y Nagai, T Ishimoto, Y Baba, K Mimori and H Baba Br J Cancer 2012 107: 1233-1238; advance online publication, September 6, 2012; 10.1038/bjc.2012.396 Abstract | Full Text | | | | Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer Y Ohi, Y Umekita, Y Sagara, Y Rai, D Yotsumoto, A Matsukata, S Baba, S Tamada, Y Matsuyama, M Ando, Y Sagara, M Sasaki, S Tsuchimochi, A Tanimoto and Y Sagara Br J Cancer 2012 107: 1239-1243; advance online publication, August 28, 2012; 10.1038/bjc.2012.387 Abstract | Full Text | | | | Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival T Gary, K Belaj, K Steidl, M Pichler, F Eisner, H Stöger, F Hafner, H Froehlich, H Samonigg, E Pilger and M Brodmann Br J Cancer 2012 107: 1244-1248; advance online publication, September 11, 2012; 10.1038/bjc.2012.401 Abstract | Full Text | | | | Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Catalonia, Spain R Font, J A Espinas, M Gil-Gil, A Barnadas, B Ojeda, I Tusquets, M A Segui, M Margelí, A Arcusa, A Prat, M Garcia and J M Borras Br J Cancer 2012 107: 1249-1256; advance online publication, September 6, 2012; 10.1038/bjc.2012.389 Abstract | Full Text | | | | Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials H M Earl, L Hiller, J A Dunn, A-L Vallier, S J Bowden, S D Jordan, F Blows, A Munro, S Bathers, R Grieve, D A Spooner, R Agrawal, I Fernando, A M Brunt, S M O'Reilly, S M Crawford, D W Rea, P Simmonds, J L Mansi, A Stanley, K McAdam, L Foster, R CF Leonard, C J Twelves, D Cameron, J MS Bartlett, P Pharoah, E Provenzano, C Caldas and C J Poole for the NEAT Investigators and the SCTBG Br J Cancer 2012 107: 1257-1267; advance online publication, September 11, 2012; 10.1038/bjc.2012.370 Abstract | Full Text | | | | Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours L P Martin, M F Kozloff, R S Herbst, T A Samuel, S Kim, B Rosbrook, M Tortorici, Y Chen, J Tarazi, A J Olszanski, T Rado, A Starr and R B Cohen Br J Cancer 2012 107: 1268-1276; advance online publication, September 20, 2012; 10.1038/bjc.2012.407 Abstract | Full Text | | | | Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumours M F Kozloff, L P Martin, M Krzakowski, T A Samuel, T A Rado, E Arriola, J De Castro Carpeño, R S Herbst, J Tarazi, S Kim, B Rosbrook, M Tortorici, A J Olszanski and R B Cohen Br J Cancer 2012 107: 1277-1285; advance online publication, September 18, 2012; 10.1038/bjc.2012.406 Abstract | Full Text | | | | Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer E Rossi, M Fassan, M Aieta, F Zilio, R Celadin, M Borin, A Grassi, L Troiani, U Basso, C Barile, T Sava, C Lanza, L Miatello, A Jirillo, M Rugge, S Indraccolo, M Cristofanilli, A Amadori and R Zamarchi Br J Cancer 2012 107: 1286-1294; advance online publication, September 6, 2012; 10.1038/bjc.2012.388 Abstract | Full Text | | | | Quality of life in participants of a CRC screening program A Kapidzic, I J Korfage, L van Dam, A HC van Roon, J CIY Reijerink, A G Zauber, M van Ballegooijen, E J Kuipers and M E van Leerdam Br J Cancer 2012 107: 1295-1301; advance online publication, September 6, 2012; 10.1038/bjc.2012.386 Abstract | Full Text | | Translational Therapeutics | Top | | Human responses against HER-2-positive cancer cells in human immune system-engrafted mice C De Giovanni, G Nicoletti, L Landuzzi, F Romani, S Croci, A Palladini, A Murgo, A Antognoli, M L Ianzano, V Stivani, V Grosso, M Iezzi, L Stramucci, E Barbieri, R M Lemoli, P Nanni and P-L Lollini Br J Cancer 2012 107: 1302-1309; advance online publication, August 28, 2012; 10.1038/bjc.2012.394 Abstract | Full Text | | | | Overestimation of carboplatin doses is avoided by radionuclide GFR measurement A J Craig, J Samol, S D Heenan, A G Irwin and A Britten Br J Cancer 2012 107: 1310-1316; advance online publication, August 30, 2012; 10.1038/bjc.2012.393 Abstract | Full Text | | | | Erythropoietin-driven signalling and cell migration mediated by polyADP-ribosylation D Inbar, M Cohen-Armon and D Neumann Br J Cancer 2012 107: 1317-1326; advance online publication, September 6, 2012; 10.1038/bjc.2012.395 Abstract | Full Text | | | | Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer G Smith, M T H Ng, L Shepherd, C S Herrington, C Gourley, M J Ferguson and C R Wolf Br J Cancer 2012 107: 1327-1336; advance online publication, September 18, 2012; 10.1038/bjc.2012.410 Abstract | Full Text | | Molecular Diagnostics | Top | | Gut microbiota-derived propionate reduces cancer cell proliferation in the liver L B Bindels, P Porporato, E M Dewulf, J Verrax, A M Neyrinck, J C Martin, K P Scott, P Buc Calderon, O Feron, G G Muccioli, P Sonveaux, P D Cani and N M Delzenne Br J Cancer 2012 107: 1337-1344; advance online publication, September 13, 2012; 10.1038/bjc.2012.409 Abstract | Full Text | | | | Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases S Akiyoshi, T Fukagawa, H Ueo, M Ishibashi, Y Takahashi, M Fabbri, M Sasako, Y Maehara, K Mimori and M Mori Br J Cancer 2012 107: 1345-1353; advance online publication, September 6, 2012; 10.1038/bjc.2012.326 Abstract | Full Text | | | | MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer S Ali, H Saleh, S Sethi, F H Sarkar and P A Philip Br J Cancer 2012 107: 1354-1360; advance online publication, August 28, 2012; 10.1038/bjc.2012.383 Abstract | Full Text | | | | miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence H Salim, N S Akbar, D Zong, A H Vaculova, R Lewensohn, A Moshfegh, K Viktorsson and B Zhivotovsky Br J Cancer 2012 107: 1361-1373; advance online publication, August 28, 2012; 10.1038/bjc.2012.382 Abstract | Full Text | | | | Notch-mediated induction of N-cadherin and α9-integrin confers higher invasive phenotype on rhabdomyosarcoma cells A Masià, A Almazán-Moga, P Velasco, J Reventós, N Torán, J Sánchez de Toledo, J Roma and S Gallego Br J Cancer 2012 107: 1374-1383; advance online publication, September 13, 2012; 10.1038/bjc.2012.411 Abstract | Full Text | | | | Diagnosis of bladder cancer by immunocytochemical detection of minichromosome maintenance protein-2 in cells retrieved from urine K Saeb-Parsy, A Wilson, C Scarpini, M Corcoran, S Chilcott, M McKean, B Thottakam, B Rai, G Nabi, D Rana, M Perera, K Stewart, R A Laskey, D E Neal and N Coleman Br J Cancer 2012 107: 1384-1391; advance online publication, September 11, 2012; 10.1038/bjc.2012.381 Abstract | Full Text | | Genetics and Genomics | Top | | Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR L Dyrskjøt, T Reinert, A Novoradovsky, T C M Zuiverloon, W Beukers, E Zwarthoff, N Malats, F X Real, U Segersten, P-U Malmström, M Knowles, C Hurst, J Sorge, M Borre and T F Ørntoft Br J Cancer 2012 107: 1392-1398; advance online publication, September 13, 2012; 10.1038/bjc.2012.412 Abstract | Full Text | | | | Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours A O von Bueren, M D Bacolod, C Hagel, K Heinimann, A Fedier, U Kordes, T Pietsch, J Koster, M A Grotzer, H S Friedman, G Marra, M Kool and S Rutkowski Br J Cancer 2012 107: 1399-1408; advance online publication, September 13, 2012; 10.1038/bjc.2012.403 Abstract | Full Text | | | | Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome A Schramm, B Schowe, K Fielitz, M Heilmann, M Martin, T Marschall, J Köster, J Vandesompele, J Vermeulen, K de Preter, J Koster, R Versteeg, R Noguera, F Speleman, S Rahmann, A Eggert, K Morik and J H Schulte Br J Cancer 2012 107: 1409-1417; 10.1038/bjc.2012.391 Abstract | Full Text | | | | Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project G Schleiermacher, V Mosseri, W B London, J M Maris, G M Brodeur, E Attiyeh, M Haber, J Khan, A Nakagawara, F Speleman, R Noguera, G P Tonini, M Fischer, I Ambros, T Monclair, K K Matthay, P Ambros, S L Cohn and A D J Pearson Br J Cancer 2012 107: 1418-1422; advance online publication, September 13, 2012; 10.1038/bjc.2012.375 Abstract | Full Text | | | | The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma E Hatzimichael, C Lo Nigro, L Lattanzio, N Syed, R Shah, A Dasoula, K Janczar, D Vivenza, M Monteverde, M Merlano, A Papoudou-Bai, M Bai, P Schmid, J Stebbing, M Bower, M J S Dyer, L E Karran, C ElguetaKarstegl, P J Farrell, A Thompson, E Briasoulis and T Crook Br J Cancer 2012 107: 1423-1432; advance online publication, September 6, 2012; 10.1038/bjc.2012.380 Abstract | Full Text | | | | Genomic Grade Index predicts postoperative clinical outcome of GIST F Bertucci, P Finetti, J Ostrowski, W K Kim, H Kim, M A Pantaleo, A Astolfi, M Polkowski and D Birnbaum Br J Cancer 2012 107: 1433-1441; advance online publication, August 28, 2012; 10.1038/bjc.2012.390 Abstract | Full Text | | Letters to the Editor | Top | | KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary J-N Vauthey, S Kopetz, T A Aloia and A Andreou Br J Cancer 2012 107: 1442-1443; advance online publication, September 27, 2012; 10.1038/bjc.2012.419 Full Text | | | | Reply: KRAS mutation in colorectal cancer metastases after adjuvant folfox for the primary T Yoshino, Y Kawamoto, H Bando and K Tsuchihara Br J Cancer 2012 107: 1444; advance online publication, September 27, 2012; 10.1038/bjc.2012.420 Full Text | | | | | | | Advertisement | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | |
| |
No comments:
Post a Comment